Tuesday, October 30, 2018

Amgen Raises Guidance - Quick Facts

Amgen (AMGN) reported that, for the full year 2018, the company now expects: total revenues in the range of $23.2 billion to $23.5 billion (prior guidance in the range of $22.5 billion to $23.2 billion). On a non-GAAP basis, EPS is now expected in the range of $14.00 to $14.25 (prior guidance, $13.30 to $14.00).

from RTT - Earnings https://ift.tt/2qkb8v7
via IFTTT

No comments:

Post a Comment